Skip to Content

Hoth Therapeutics, Inc.

Merger

  • Date:
  • 4/26/2023
  • Company Name:
  • Hoth Therapeutics, Inc.
  • Stock Symbol:
  • HOTH
  • Company Name - Buyer:
  • Algorithm Sciences, Inc.
  • Status:
  • Investigating
  • Merger Announcement Date:
  • 4/26/2023

Case Finder

Locate any case using the tools below.

NEW YORK, April 26, 2023 – Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, has launched an investigation into whether the officers or directors of Hoth Therapeutics, Inc. (NASDAQ: HOTH) (“Hoth”) breached their fiduciary duties or violated the federal securities laws in connection with the company’s acquisition by Algorithm Sciences, Inc. (“Algorithm”).

On April 26, 2023, Hoth announced that it had entered into an agreement to be acquired by Algorithm in an all-stock deal. Pursuant to the merger agreement, current Hoth shareholders are currently anticipated to own approximately 14% of the combined company and current Algorithm shareholders are currently anticipated to own approximately 86% of the combined company.

Bragar Eagel & Squire is concerned that Hoth’s board of directors oversaw an unfair process and ultimately agreed to an inadequate merger agreement. Accordingly, the firm is investigating all relevant aspects of the deal and is committed to securing the best result possible for Hoth’s stockholders.
The individual or institution below (“Plaintiff”) has reviewed and agrees to the Bragar Eagel & Squire, P.C. (“BESPC”) retainer agreement and authorizes BESPC to prosecute an action on Plaintiff’s behalf under the federal securities laws or applicable state laws to recover damages on behalf of investors in Hoth Therapeutics. BESPC will prosecute the action on a full contingency basis and will forward all costs and expenses.
 

Case Finder

Locate any case using the tools below.

You may share a link to this page on any of the sites listed below or send link via email: